Discovery of Anti-miR-17 Oligonucleotide RGLS4326 for the Treatment of Autosomal Dominant Polycystic Kidney Disease. Discovery of Anti-miR-17 Oligonucleotide RGLS4326 for the Treatment of Autosomal Dominant Polycystic Kidney Disease Post navigation Previous: Preclinical Development of miR-10B Antagonist for the Treatment of GlioblastomaNext: Development of Oligonucleotide-Based miR-132 Antagonists for the Treatment of NASH
Discovery of Anti-miR-17 Oligonucleotide RGLS4326 for the Treatment of Autosomal Dominant Polycystic Kidney Disease